Tracy Snyder Email and Phone Number

US commercial insights for Vonjo and Doptelet

Global commercial insights and forecasting for the NSCLC PDx1 and EGFR markets, and commercial insights in autoimmune JAK and breast cancer CDK4/6 markets- Develop patient flow, event-based monthly forecasts with multiple scenarios for US, EU4, and UK markets- Data triangulation, market segmentation, competitive landscape analysis, storytelling- Cross-functional alignment of assumption inputs for demand forecast models- Provide epidemiology and regulatory analyses for potential indications- Inform launch sequencing by understanding the nuances in markets outside of the G7 countries- Contribute to BD efforts including potential market capture, scenario analysis, and NPV assessment

Global pharmaceutical market intelligence with a focus in blood plasma products and rare diseases (hemophilia, MG, ITP, PID, CIDP, MMN, etc.)- Product strategy- Market assessment- Forecasting- Competitive Intelligence- HEOR

Conducted translational research for the purpose of licensing technologies and building marketable products/services. Focused on ultrasound stimulated drug release, prodrug therapies, and material development for drug delivery.

Responsible for the manufacturing of Alpha Technology catalog and custom products. Routinely carried out antibody lyophilization, biotinylation, purification, and conjugation to latex-based beads. Trained in radiochemical handling/processing and HPLC purifications. Proficient in NPI processes, writing and maintaining SOP documents, and processing customer complaints and custom orders.

Senior Thesis: Synthesis of Anti-Malarial Polycyclic Ketals and 1,2,3-triazole HDAC 8 InhibitorsSynthesized selective HDAC 8 inhibitors in parallel. Synthesized and diversified rhodium catalyzed polycyclic ketals for anti-malarial testing. Synthesized and diversified o-alkynyl benzaldehyde dimers. Assisted in multidimensional screening and methodology development for condensations involving complex 1,2-diketones.